Position in NVAX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$82,547
-$16,169 QoQ
Shares Held
10,141
-10.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,874,071,197 across 105 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in NVAX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,547 | 10,141 | Shares | Defined | 2026-05-04 | |
| 2025-09-30 | $98,716 | 11,386 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $66,654 | 10,580 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $76,362 | 11,913 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $97,983 | 12,187 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $156,851 | 12,419 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $298,738 | 23,597 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $127,563 | 26,687 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $118,660 | 24,721 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $170,154 | 23,502 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $174,091 | 23,431 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $138,662 | 20,009 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $224,771 | 21,865 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $326,197 | 17,923 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $993,575 | 19,319 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,310,158 | 17,789 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $2,694,580 | 18,834 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $9,670,803 | 46,649 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $5,226,222 | 24,616 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,965,430 | 21,871 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $2,199,310 | 19,723 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $1,646,486 | 15,196 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $1,419,283 | 17,028 | Shares | Defined | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||